Sruti Shiva, professor of pharmacology and chemical biology, School of Medicine, has been appointed scientific director of the Hemophilia Center of Western Pennsylvania (HCWP).
She joined the faculty of the University of Pittsburgh in 2008 as an assistant professor, after earning her PhD from the University of Alabama in Birmingham and completing postdoctoral training at the National Heart, Lung and Blood Institute, National Institutes of Health.
Shiva is an accomplished basic and translational scientist, whose extramurally funded research program focuses on elucidating the mechanisms regulating mitochondrial function and signaling. More recently, her laboratory has focused on the role of mitochondrial function in platelet activation, and how this process regulates thrombosis and signaling in hematological disease. She has made seminal contributions to the fields of mitochondrial function and platelet biology, with more than 200 publications to date. She is a professor in the Vascular Medicine Institute (VMI) and Division of Classical Hematology, where she continues to advance her research and teaching priorities in hematology, alongside her roles as director of the VMI T32 training program and vice chair for basic and translational research in the Department of Medicine.
In her new role, Shiva will oversee the basic and translational research operations of the HCWP, a state and federally funded charitable organization that provides comprehensive medical care to patients with hemophilia and other bleeding and clotting disorders. In addition to patient care, and in part overseen by Vitalant (the nation’s largest independent nonprofit blood services provider), the HCWP performs a range of basic, translational and clinical studies aimed at improving the lives of people with hematological diseases.
This appointment highlights the strong connection between the VMI, the Division of Classical Hematology, Vitalant and the HCWP, which has provided valuable support to the VMI since 2008.